sales@fnfresearch.comTel: +86 21 80360450 | USA: +1-347-989-3985

Search Market Research Report

Home / Healthcare / Pharmacovigilance and Drug Safety Software

Pharmacovigilance and Drug Safety Software Market By Type (On-Premise and Cloud-based), By Application (Pharma and Biotech, Companies Contract Research Organizations (CROs), and Business Process Outsourcing (BPO) Firms), and By Regions: Global Industry Perspective, Comprehensive Analysis, and Forecast, 2019 – 2026

  • Publish On: Feb-2020
  • Total Pages: 110
  • Report Code: FAF-468
  • Base Year: 2019
  • Format:

Industry Insights

This professional and specialized report study examines the technical and business perspective of the Pharmacovigilance and Drug Safety Software industry. The report provides a historical analysis of the industry as well as the projected trends expected to be witnessed in the global Pharmacovigilance and Drug Safety Software market. The report study analyzes the market statistics at the global as well as the regional levels to gain an in-depth perspective of the overall Pharmacovigilance and Drug Safety Software market. The historical insights are provided from 2016 to 2019 and projected trends are provided from 2020 to 2026. The quantitative data is provided in terms of value (USD Million) for 2016 – 2026. The qualitative data is reinforced by analyzing and providing numerous market dynamics (directly or indirectly affecting the industry) such as growth drivers, restraints, challenges, and opportunities.

We have included various industry analysis models in our report and extensively demonstrated the key business strategies and competitive landscape of the global Pharmacovigilance and Drug Safety Software market in our study.

Our study also includes an analysis of Porter’s Five Forces framework for understanding the competitive strategies adopted by various stakeholders involved in the entire value chain of the global Pharmacovigilance and Drug Safety Software market. It also encompasses PESTLE analysis and SWOT analysis.

The report also offers an in-depth analysis of the market shares of each industry player and gives an outline of the market position of key players in the global Pharmacovigilance and Drug Safety Software market. Moreover, the study offers wide coverage of key strategic advances witnessed in the market such as new product launches, acquisitions & mergers, collaborations & joint ventures, funding & VC activities, agreements, partnerships, R&D activities, and regional expansion of key players of the global Pharmacovigilance and Drug Safety Software market.

The research study provides a critical assessment of the Pharmacovigilance and Drug Safety Software industry by logically segmenting the market on the basis of Type, Application, and regions. Based on the past, present, and future trends, all the segments were analyzed from the bottom up, and the market sizes have been estimated from 2020 to 2026. The regional segmentation of the Pharmacovigilance and Drug Safety Software industry includes the holistic bifurcation of all the five major continents including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

Pharmacovigilance basically helps monitor medical drug’s effects after being licensed. It is carried out to understand the earlier observed uncomplimentary reactions of the medical drug.  In simple words, it is just to verify the safety of the drug. Pharmacovigilance (PV) software consists of a drug safety management software solution to help develop, categorize, review, submit and maintain pharmacovigilance data plus adverse event reports.

The increasing demand for medications across the entire globe has made it mandatory for the manufacturers to produce safe drugs and this increasing pressure on various biotech and Pharma companies are expected to supplement substantial Pharmacovigilance and Drug Safety Software market growth over the forecast period. Real-time data analysis of network data, customers, users and investors’ data from the datacenters or cloud system help create a learning protocol and system, which is likely to propel the Pharmacovigilance and Drug Safety Software market during the forecast period. Additionally, the high incidence of ADRs is anticipated to boost the growth of the pharmacovigilance and drug safety software market. However, the lack of knowledge about ADRs and the lack of standard regulations in adverse drug reaction reporting in the developing countries is anticipated to have a negative impact on the global Pharmacovigilance and Drug Safety Software market.

The global Sewing Threads market is segmented based on Type and Application. Based on type, the market is divided into On-Premise and Cloud-based. On the basis of application, the market for Pharmacovigilance and Drug Safety Software is segmented into pharma and Biotech, Companies  Contract Research Organizations (CROs), and Business Process Outsourcing (BPO) Firms.

Some of the essential players operating in the global Pharmacovigilance And Drug Safety Software market, but not restricted to include Max Application Srl, ArisGlobal, Ennov Solutions Inc., Anju Software Inc., EXTEDO GmbH, AB Cube, Oracle Corporation, Sparta Systems, Inc., Sarjen Systems Pvt. Ltd., and Pegasystems Inc.

The taxonomy of the Pharmacovigilance and Drug Safety Software Market by its scope and segmentation is as follows:

Global Pharmacovigilance and Drug Safety Software Market: By Type Segmentation Analysis

  • On-Premise
  • Cloud-based

Global Pharmacovigilance and Drug Safety Software Market: By Application Segmentation Analysis

  • Pharma and Biotech Companies
  • Contract Research Organizations (CROs)
  • Business Process Outsourcing (BPO) Firms

Global Pharmacovigilance and Drug Safety Software Market: Regional Segmentation Analysis

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

KEY BUSINESS POINTERS ADDRESSED & FOREMOST REASONS TO PROCURE THE REPORT:

  • Statistical Analysis of the Past, Current, and Future Trends of the Industry with Validated Market Sizes Data
  • Direct and Indirect Rationales Impacting the Industry
  • In-depth and Micro Analysis of Viable Segments and Sub-segments
  • Companies and Vendors Market Share, Competitive Landscape, and Player Positioning Analysis
  • Demand Side (Consumption) and Supply Side (Production) Perspective and Analysis wherever applicable
  • Key Buyers and End-Users Analysis
  • Value Chain and Manufacturing Cost Structure Analysis wherever relevant
  • Key Marketing Strategies as well as Key Sales Channels adopted in the market
  • Investment Opportunity Analysis & Patents Analysis wherever feasible
  • Technological Road Map & Technical Analysis
  • Robust Research Methodology comprising dynamic mix (65%~35%) of Extensive Primary Research (primary interviews, ad-hoc surveys, questionnaires) and Protracted Secondary Research (proprietary in-house database, paid external databases, publically available validated sources)

Table of Content

  1. CHAPTER 1. Executive Summary
  2. CHAPTER 2. Pharmacovigilance and Drug Safety Software market – Type Analysis
    1. 2.1. Global Pharmacovigilance and Drug Safety Software Market – Type Overview
    2. 2.2. Global Pharmacovigilance and Drug Safety Software Market Share, by Type, 2018 & 2025 (USD Million)
    3. 2.3. On-Premise
      1. 2.3.1. Global On-Premise Pharmacovigilance and Drug Safety Software Market, 2016-2026 (USD Million)
    4. 2.4. Cloud-based
      1. 2.4.1. Global Cloud-based Pharmacovigilance and Drug Safety Software Market, 2016-2026 (USD Million)
  3. CHAPTER 3. Pharmacovigilance and Drug Safety Software market – Application Analysis
    1. 3.1. Global Pharmacovigilance and Drug Safety Software Market – Application Overview
    2. 3.2. Global Pharmacovigilance and Drug Safety Software Market Share, by Application, 2018 & 2025 (USD Million)
    3. 3.3. Pharma and Biotech
      1. 3.3.1. Global Pharma and Biotech Pharmacovigilance and Drug Safety Software Market, 2016-2026 (USD Million)
    4. 3.4. Companies Contract Research Organizations (CROs)
      1. 3.4.1. Global Companies Contract Research Organizations (CROs) Pharmacovigilance and Drug Safety Software Market, 2016-2026 (USD Million)
    5. 3.5. Business Process Outsourcing (BPO) Firms
      1. 3.5.1. Global Business Process Outsourcing (BPO) Firms Pharmacovigilance and Drug Safety Software Market, 2016-2026 (USD Million)
  4. CHAPTER 4. Pharmacovigilance and Drug Safety Software market – Regional Analysis
    1. 4.1. Global Pharmacovigilance and Drug Safety Software Market Regional Overview
    2. 4.2. Global Pharmacovigilance and Drug Safety Software Market Share, by Region, 2018 & 2025 (Value)
    3. 4.3. North America
      1. 4.3.1. North America Pharmacovigilance and Drug Safety Software Market size and forecast, 2016-2026
      2. 4.3.2. North America Pharmacovigilance and Drug Safety Software Market, by Country, 2018 & 2025 (USD Million)
      3. 4.3.3. North America Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026
        1. 4.3.3.1. North America Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026 (USD Million)
      4. 4.3.4. North America Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026
        1. 4.3.4.1. North America Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026 (USD Million)
      5. 4.3.5. U.S.
        1. 4.3.5.1. U.S. Market size and forecast, 2016-2026 (USD Million)
      6. 4.3.6. Canada
        1. 4.3.6.1. Canada Market size and forecast, 2016-2026 (USD Million)
    4. 4.4. Europe
      1. 4.4.1. Europe Pharmacovigilance and Drug Safety Software Market size and forecast, 2016-2026
      2. 4.4.2. Europe Pharmacovigilance and Drug Safety Software Market, by Country, 2018 & 2025 (USD Million)
      3. 4.4.3. Europe Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026
        1. 4.4.3.1. Europe Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026 (USD Million)
      4. 4.4.4. Europe Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026
        1. 4.4.4.1. Europe Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026 (USD Million)
      5. 4.4.5. Germany
        1. 4.4.5.1. Germany Market size and forecast, 2016-2026 (USD Million)
      6. 4.4.6. France
        1. 4.4.6.1. France Market size and forecast, 2016-2026 (USD Million)
      7. 4.4.7. U.K.
        1. 4.4.7.1. U.K. Market size and forecast, 2016-2026 (USD Million)
      8. 4.4.8. Italy
        1. 4.4.8.1. Italy Market size and forecast, 2016-2026 (USD Million)
      9. 4.4.9. Spain
        1. 4.4.9.1. Spain Market size and forecast, 2016-2026 (USD Million)
      10. 4.4.10. Rest of Europe
        1. 4.4.10.1. Rest of Europe Market size and forecast, 2016-2026 (USD Million)
    5. 4.5. Asia Pacific
      1. 4.5.1. Asia Pacific Pharmacovigilance and Drug Safety Software Market size and forecast, 2016-2026
      2. 4.5.2. Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Country, 2018 & 2025 (USD Million)
      3. 4.5.3. Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026
        1. 4.5.3.1. Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026 (USD Million)
      4. 4.5.4. Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026
        1. 4.5.4.1. Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026 (USD Million)
      5. 4.5.5. China
        1. 4.5.5.1. China Market size and forecast, 2016-2026 (USD Million)
      6. 4.5.6. Japan
        1. 4.5.6.1. Japan Market size and forecast, 2016-2026 (USD Million)
      7. 4.5.7. India
        1. 4.5.7.1. India Market size and forecast, 2016-2026 (USD Million)
      8. 4.5.8. South Korea
        1. 4.5.8.1. South Korea Market size and forecast, 2016-2026 (USD Million)
      9. 4.5.9. South-East Asia
        1. 4.5.9.1. South-East Asia Market size and forecast, 2016-2026 (USD Million)
      10. 4.5.10. Rest of Asia Pacific
        1. 4.5.10.1. Rest of Asia Pacific Market size and forecast, 2016-2026 (USD Million)
    6. 4.6. Latin America
      1. 4.6.1. Latin America Pharmacovigilance and Drug Safety Software Market size and forecast, 2016-2026
      2. 4.6.2. Latin America Pharmacovigilance and Drug Safety Software Market, by Country, 2018 & 2025 (USD Million)
      3. 4.6.3. Latin America Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026
        1. 4.6.3.1. Latin America Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026 (USD Million)
      4. 4.6.4. Latin America Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026
        1. 4.6.4.1. Latin America Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026 (USD Million)
      5. 4.6.5. Brazil
        1. 4.6.5.1. Brazil Market size and forecast, 2016-2026 (USD Million)
      6. 4.6.6. Mexico
        1. 4.6.6.1. Mexico Market size and forecast, 2016-2026 (USD Million)
      7. 4.6.7. Rest of Latin America
        1. 4.6.7.1. Rest of Latin America Market size and forecast, 2016-2026 (USD Million)
    7. 4.7. The Middle-East and Africa
      1. 4.7.1. The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market size and forecast, 2016-2026
      2. 4.7.2. The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Country, 2018 & 2025 (USD Million)
      3. 4.7.3. The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026
        1. 4.7.3.1. The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026 (USD Million)
      4. 4.7.4. The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026
        1. 4.7.4.1. The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026 (USD Million)
      5. 4.7.5. GCC Countries
        1. 4.7.5.1. GCC Countries Market size and forecast, 2016-2026 (USD Million)
      6. 4.7.6. South Africa
        1. 4.7.6.1. South Africa Market size and forecast, 2016-2026 (USD Million)
      7. 4.7.7. Rest of Middle-East Africa
        1. 4.7.7.1. Rest of Middle-East Africa Market size and forecast, 2016-2026 (USD Million)
  5. CHAPTER 5. Pharmacovigilance and Drug Safety Software market – Competitive Landscape
    1. 5.1. Competitor Market Share – Revenue
    2. 5.2. Market Concentration Rate Analysis, Top 3 and Top 5 Players
    3. 5.3. Strategic Development
      1. 5.3.1. Acquisitions and Mergers
      2. 5.3.2. New Products
      3. 5.3.3. Research & Development Activities
  6. CHAPTER 6. Company Profiles
    1. 6.1. ArisGlobal
      1. 6.1.1. Company Overview
      2. 6.1.2. ArisGlobal Revenue and Gross Margin
      3. 6.1.3. Product portfolio
      4. 6.1.4. Recent initiatives
    2. 6.2. Ennov Solutions Inc.
      1. 6.2.1. Company Overview
      2. 6.2.2. Ennov Solutions Inc. Revenue and Gross Margin
      3. 6.2.3. Product portfolio
      4. 6.2.4. Recent initiatives
    3. 6.3. EXTEDO GmbH
      1. 6.3.1. Company Overview
      2. 6.3.2. EXTEDO GmbH Revenue and Gross Margin
      3. 6.3.3. Product portfolio
      4. 6.3.4. Recent initiatives
    4. 6.4. Anju Software Inc.
      1. 6.4.1. Company Overview
      2. 6.4.2. Anju Software Inc. Revenue and Gross Margin
      3. 6.4.3. Product portfolio
      4. 6.4.4. Recent initiatives
    5. 6.5. Oracle Corporation
      1. 6.5.1. Company Overview
      2. 6.5.2. Oracle Corporation Revenue and Gross Margin
      3. 6.5.3. Product portfolio
      4. 6.5.4. Recent initiatives
    6. 6.6. Sarjen Systems Pvt. Ltd.
      1. 6.6.1. Company Overview
      2. 6.6.2. Sarjen Systems Pvt. Ltd. Revenue and Gross Margin
      3. 6.6.3. Product portfolio
      4. 6.6.4. Recent initiatives
    7. 6.7. Sparta Systems Inc.
      1. 6.7.1. Company Overview
      2. 6.7.2. Sparta Systems Inc. Revenue and Gross Margin
      3. 6.7.3. Product portfolio
      4. 6.7.4. Recent initiatives
    8. 6.8. AB Cube
      1. 6.8.1. Company Overview
      2. 6.8.2. AB Cube Revenue and Gross Margin
      3. 6.8.3. Product portfolio
      4. 6.8.4. Recent initiatives
    9. 6.9. Max Application Srl
      1. 6.9.1. Company Overview
      2. 6.9.2. Max Application Srl Revenue and Gross Margin
      3. 6.9.3. Product portfolio
      4. 6.9.4. Recent initiatives
    10. 6.10. Pegasystems Inc.
      1. 6.10.1. Company Overview
      2. 6.10.2. Pegasystems Inc. Revenue and Gross Margin
      3. 6.10.3. Product portfolio
      4. 6.10.4. Recent initiatives
  7. CHAPTER 7. Pharmacovigilance and Drug Safety Software — Industry Analysis
    1. 7.1. Pharmacovigilance and Drug Safety Software Market – Key Trends
      1. 7.1.1. Market Drivers
      2. 7.1.2. Market Restraints
      3. 7.1.3. Market Opportunities
    2. 7.2. Value Chain Analysis
    3. 7.3. Technology Roadmap and Timeline
    4. 7.4. Pharmacovigilance and Drug Safety Software Market – Attractiveness Analysis
      1. 7.4.1. By Type
      2. 7.4.2. By Application
      3. 7.4.3. By Region
  8. CHAPTER 8. Marketing Strategy Analysis, Distributors
    1. 8.1. Marketing Channel
    2. 8.2. Direct Marketing
    3. 8.3. Indirect Marketing
    4. 8.4. Marketing Channel Development Trend
    5. 8.5. Economic/Political Environmental Change
  9. CHAPTER 9. Report Conclusion
  10. CHAPTER 10. Research Approach & Methodology
    1. 10.1. Report Description
    2. 10.2. Research Scope
    3. 10.3. Research Methodology
      1. 10.3.1. Secondary Research
      2. 10.3.2. Primary Research
      3. 10.3.3. Models
        1. 10.3.3.1. Company Share Analysis Model
        2. 10.3.3.2. Revenue Based Modeling
        3. 10.3.3.3. Research Limitations

        List of Figures

        FIG. 1 Global Pharmacovigilance and Drug Safety Software Market, 2016-2026 (USD Million)
        FIG. 2 Global Pharmacovigilance and Drug Safety Software Market Share, by Type, 2018 & 2025 (USD Million)
        FIG. 3 Global On-Premise Pharmacovigilance and Drug Safety Software Market, 2016-2026 (USD Million)
        FIG. 4 Global Cloud-based Pharmacovigilance and Drug Safety Software Market, 2016-2026 (USD Million)
        FIG. 5 Global Pharmacovigilance and Drug Safety Software Market Share, by Application, 2018 & 2025 (USD Million)
        FIG. 6 Global Pharma and Biotech Pharmacovigilance and Drug Safety Software Market, 2016-2026 (USD Million)
        FIG. 7 Global Companies  Contract Research Organizations (CROs) Pharmacovigilance and Drug Safety Software Market, 2016-2026 (USD Million)
        FIG. 8 Global Business Process Outsourcing (BPO) Firms Pharmacovigilance and Drug Safety Software Market, 2016-2026 (USD Million)
        FIG. 9 Global Pharmacovigilance and Drug Safety Software Market Share, by Region, 2018 & 2025
        FIG. 10 North America Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 11 U.S. Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 12 Canada Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 13 Europe Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 14 Germany Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 15 France Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 16 U.K. Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 17 Italy Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 18 Spain Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 19 Rest of Europe Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 20 Asia Pacific Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 21 China Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 22 Japan Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 23 India Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 24 South  Korea Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 25 South-East Asia Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 26 Rest of Asia Pacific Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 27 Latin America Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 28 Brazil Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 29 Mexico Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 30 Rest of Latin America Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 31 The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 32 GCC Countries Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 33 South Africa Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 34 Rest of Middle-East Africa Pharmacovigilance and Drug Safety Software Market, 2016-2026
        FIG. 35 Competitor Market Share – Revenue
        FIG. 36 ArisGlobal Revenue and Growth Rate
        FIG. 37 ArisGlobal Market Share
        FIG. 38 Ennov Solutions Inc. Revenue and Growth Rate
        FIG. 39 Ennov Solutions Inc. Market Share
        FIG. 40 EXTEDO GmbH Revenue and Growth Rate
        FIG. 41 EXTEDO GmbH Market Share
        FIG. 42 Anju Software Inc. Revenue and Growth Rate
        FIG. 43 Anju Software Inc. Market Share
        FIG. 44 Oracle Corporation Revenue and Growth Rate
        FIG. 45 Oracle Corporation Market Share
        FIG. 46 Sarjen Systems Pvt. Ltd. Revenue and Growth Rate
        FIG. 47 Sarjen Systems Pvt. Ltd. Market Share
        FIG. 48 Sparta Systems Inc. Revenue and Growth Rate
        FIG. 49 Sparta Systems Inc. Market Share
        FIG. 50 AB Cube Revenue and Growth Rate
        FIG. 51 AB Cube Market Share
        FIG. 52 Max Application Srl Revenue and Growth Rate
        FIG. 53 Max Application Srl Market Share
        FIG. 54 Pegasystems Inc. Revenue and Growth Rate
        FIG. 55 Pegasystems Inc. Market Share
        FIG. 56 Market Dynamics
        FIG. 57 Global Pharmacovigilance and Drug Safety Software – Value Chain Analysis
        FIG. 58 Technology Roadmap and Timeline
        FIG. 59 Market Attractiveness Analysis – By Type
        FIG. 60 Market Attractiveness Analysis – By Application
        FIG. 61 Market Attractiveness Analysis – By Region
        FIG. 62 Market Channel
        FIG. 63 Marketing Channel Development Trend
        FIG. 64 Growth in World Gross Product, 2008-2018
         


        List of Tables

        TABLE 1 Global Pharmacovigilance and Drug Safety Software Market, 2018 & 2025 (USD Million)
        TABLE 2 Global Pharmacovigilance and Drug Safety Software market, by Type, 2016-2026 (USD Million)
        TABLE 3 Global Pharmacovigilance and Drug Safety Software market, by Application, 2016-2026 (USD Million)
        TABLE 4 Global Pharmacovigilance and Drug Safety Software market, by Region, 2016-2026 (USD Million)
        TABLE 5 North America Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026 (USD Million)
        TABLE 6 North America Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026 (USD Million)
        TABLE 7 Europe Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026 (USD Million)
        TABLE 8 Europe Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026 (USD Million)
        TABLE 9 Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026 (USD Million)
        TABLE 10 Asia Pacific Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026 (USD Million)
        TABLE 11 Latin America Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026 (USD Million)
        TABLE 12 Latin America Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026 (USD Million)
        TABLE 13 The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Type, 2016-2026 (USD Million)
        TABLE 14 The Middle-East and Africa Pharmacovigilance and Drug Safety Software Market, by Application, 2016-2026 (USD Million)
        TABLE 15 Global Pharmacovigilance and Drug Safety Software Market - Company Revenue Analysis 2016-2019 (USD Million)
        TABLE 16 Global Pharmacovigilance and Drug Safety Software Market - Company Revenue Share Analysis 2016-2019(%)
        TABLE 17 Acquisitions and Mergers
        TABLE 18 New Product/Service Launch
        TABLE 19 Research & Development Activities
        TABLE 20 Market Drivers
        TABLE 21 Market Restraints
        TABLE 22 Market Opportunities
         

Key Insights from Primary Research

  • As per our primary research, the mounting incidences of adverse reactions in the developing or developed regions are anticipated to increase the demand for pharmacovigilance (PV) software among the business process outsourcing firms (BPOs), pharma & biotech companies, contract research organizations (CROs), and other pharmacovigilance service providers.
  • Increasing demand for various drugs and other medication across the globe along with the constant efforts of manufacturers to produce safe drugs increases the pressure on various biotech and pharma companies; thereby the market is anticipated to witness substantial growth over the forecast period.
  • For instance, as per the National Centre for Biotechnology Information 5% of the hospital admissions in Europe are due to ADR and this high incidence rate of ADR among hospitalized patientsis projected to increase demand for surge pharmacovigilance and drug safety software.
  • From our primary research, on-premise dominates the type segment owing to easy installation services & solutions on computers, low-cost maintenance, and access to remote locations.
  • Growing popularity of pharmacovigilance and drug safety software will help overcome the global concerns against medical safety issues.

Key Recommendations from Analysts

  • In terms of region, North America is likely to lead the marketover the forecast period owing to the strong government support programsinfavor of the acceptance of pharmacovigilance and drug safety software.
  • Owing to theincreasing demand for accessible, actionable drug safety insight the departmental and overall commercial success in both large and smallbiopharma companies have completely shifted their focus on the pharmacovigilance and drug safety software paradigm.
  • Rising adoption of interconnected software services by outsourcing firms increases the adoption of pharmacovigilance and drug safety software.
  • High acceptance of Pharmacovigilance (PV) software solutions by pharma and biotech companies to reduce medical expenditure and also to facilitate clinical trial accounted for the acceleration of the Pharma and Biotech Companies category.
  • Mounting level of drug abuse and related adverse drug reactions are leading to higher morbidity and death rate plus the development of new drugs acts as high growth rendering factors for the market in North America. 

Global Market Attractiveness in 2019: By Regional Segmentation Analysis

Global Pharmacovigilance and Drug Safety Software Market

Industry Major Market Players

  • Max Application Srl
  • ArisGlobal
  • Ennov Solutions Inc.
  • Anju Software Inc.
  • EXTEDO GmbH
  • AB Cube
  • Oracle Corporation
  • Sparta Systems Inc.
  • Sarjen Systems Pvt. Ltd.
  • Pegasystems Inc.

Safe and Secure SSL Encrypted

Choose License Type

Inquiry For Buying
have a question

HAVE A QUESTION? Executive will help you find what you are looking for.


REQUEST CUSTOMIZATION

Still haven't found what you're looking for? Speak to our Custom Research Team

Learn More
Facts & Factors provides an array of marketing and business research solutions distinctly designed by our expertise for the clients.
Copyright © 2020 Facts & Factors. All Rights Reserved. Sitemap - Privacy Policy - Terms & Conditions